Alpha-synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease - PubMed (original) (raw)
Alpha-synuclein up-regulates expression of caveolin-1 and down-regulates extracellular signal-regulated kinase activity in B103 neuroblastoma cells: role in the pathogenesis of Parkinson's disease
Makoto Hashimoto et al. J Neurochem. 2003 Jun.
Free article
Abstract
alpha-Synuclein accumulation plays an important role in the pathogenesis of Lewy body disease (LBD) and Parkinson's disease (PD). Although the mechanisms are not yet clear, it is possible that dysregulation of the extracellular signal-regulated kinase (ERK) might play a role. As caveolins form scaffolds onto which signaling molecules such as ERK can assemble, we propose that signaling alterations associated with alpha-synuclein accumulation and neurodegeneration, might be mediated via caveolae. Therefore, the objective of the present study was to investigate the potential contribution of alterations in the caveolar system in mediating alpha-synuclein effects on the ERK signaling pathway. For this, synuclein-transfected B103 neuroblastoma cells were used as a model system. In this cell line, caveolin-1 expression was up-regulated, whereas, ERK was down-regulated. ERK was weakly but consistently co-immunoprecipitated with alpha-synuclein but caveolin-1 did not co-immunoprecipitate with alpha-synuclein. Moreover, treatment of alpha-synuclein- overexpressing cells with caveolin-1 antisense oligonucleotides resulted in stimulation of ERK activity, with amelioration of the neuritic alterations. Transduction of alpha-synuclein-overexpressing cells, with an adenoviral vector directing the expression of ERK, resulted in suppression of caveolin-1 expression and re-establishment of the normal patterns of neurite outgrowth. These results suggest that alpha-synuclein may also interfere with ERK signaling by dysregulating caveolin-1 expression. Thus, the caveolin-1/ERK pathway could be a therapeutic target for the alpha-synuclein-related neurodegenerative disorders.
Similar articles
- MPP+ increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells.
Gómez-Santos C, Ferrer I, Reiriz J, Viñals F, Barrachina M, Ambrosio S. Gómez-Santos C, et al. Brain Res. 2002 May 10;935(1-2):32-9. doi: 10.1016/s0006-8993(02)02422-8. Brain Res. 2002. PMID: 12062470 - Reduced neuritic outgrowth and cell adhesion in neuronal cells transfected with human alpha-synuclein.
Takenouchi T, Hashimoto M, Hsu LJ, Mackowski B, Rockenstein E, Mallory M, Masliah E. Takenouchi T, et al. Mol Cell Neurosci. 2001 Jan;17(1):141-50. doi: 10.1006/mcne.2000.0923. Mol Cell Neurosci. 2001. PMID: 11161475 - alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells.
Hashimoto M, Hsu LJ, Rockenstein E, Takenouchi T, Mallory M, Masliah E. Hashimoto M, et al. J Biol Chem. 2002 Mar 29;277(13):11465-72. doi: 10.1074/jbc.M111428200. Epub 2002 Jan 14. J Biol Chem. 2002. PMID: 11790792 - Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies.
Hashimoto M, Masliah E. Hashimoto M, et al. Neurochem Res. 2003 Nov;28(11):1743-56. doi: 10.1023/a:1026073324672. Neurochem Res. 2003. PMID: 14584828 Review. - Synucleins in synaptic plasticity and neurodegenerative disorders.
Clayton DF, George JM. Clayton DF, et al. J Neurosci Res. 1999 Oct 1;58(1):120-9. J Neurosci Res. 1999. PMID: 10491577 Review.
Cited by
- α-Synuclein protects neurons from apoptosis downstream of free-radical production through modulation of the MAPK signalling pathway.
Musgrove RE, King AE, Dickson TC. Musgrove RE, et al. Neurotox Res. 2013 May;23(4):358-69. doi: 10.1007/s12640-012-9352-5. Epub 2012 Aug 31. Neurotox Res. 2013. PMID: 22936601 - Type-1 cannabinoid receptors colocalize with caveolin-1 in neuronal cells.
Bari M, Oddi S, De Simone C, Spagnolo P, Gasperi V, Battista N, Centonze D, Maccarrone M. Bari M, et al. Neuropharmacology. 2008 Jan;54(1):45-50. doi: 10.1016/j.neuropharm.2007.06.030. Epub 2007 Jul 20. Neuropharmacology. 2008. PMID: 17714745 Free PMC article. - Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux.
Marongiu R, Spencer B, Crews L, Adame A, Patrick C, Trejo M, Dallapiccola B, Valente EM, Masliah E. Marongiu R, et al. J Neurochem. 2009 Mar;108(6):1561-74. doi: 10.1111/j.1471-4159.2009.05932.x. Epub 2009 Jan 24. J Neurochem. 2009. PMID: 19166511 Free PMC article. - Protective role of endogenous gangliosides for lysosomal pathology in a cellular model of synucleinopathies.
Wei J, Fujita M, Nakai M, Waragai M, Sekigawa A, Sugama S, Takenouchi T, Masliah E, Hashimoto M. Wei J, et al. Am J Pathol. 2009 May;174(5):1891-909. doi: 10.2353/ajpath.2009.080680. Epub 2009 Apr 6. Am J Pathol. 2009. PMID: 19349362 Free PMC article. - FTY720-Mitoxy reduces toxicity associated with MSA-like α-synuclein and oxidative stress by increasing trophic factor expression and myelin protein in OLN-93 oligodendroglia cell cultures.
Vargas-Medrano J, Segura-Ulate I, Yang B, Chinnasamy R, Arterburn JB, Perez RG. Vargas-Medrano J, et al. Neuropharmacology. 2019 Nov 1;158:107701. doi: 10.1016/j.neuropharm.2019.107701. Epub 2019 Jul 7. Neuropharmacology. 2019. PMID: 31291595 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous